Page 8 - Trials Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

And im on the committee in the lung map trial, and i have really urged that we make sure that we are out there in the community so that anyone who has lung cancer has an opportunity to participate in the research and perhaps, have a more effective therapy. So, i think the Electronic Health records that its a huge different area that we are working on and how to do Clinical Trials utilizing the infrastructure that is emerging. Right, thank you very much. Chair, thanks, gentle lady, and now recognize gentleman from new jersey. Five minutes. Thank you very much, mr. Chairman. A focus of your test...

Government, as wellintentioned as they are, and i do believe that they are wellintentioned, i just simply do not think that they have the capacity. I think that there needs to be something to augment their capacity. I think that there needs to be some kind of coordination unit. Ive heard here today that the World Health Organization has the lead. Maybe, maybe not. I think something with a bit more of an operational edge to it is called for. That may be some kind of a i do not know what that could be, but more is needed. I think that if we leave the situation up to the ministries of health when...

Uganda Aids Commission says more than 50,000 Ugandans contract HIV every year, with around 17,000 HIV-related deaths among the estimated 1.4 million Ugandans living with HIV

​​This is the second of six seminars that the LSHTM Clinical Trials Network is running in 2024 on practical issues in clinical trials.  Speakers​Dr Anna Last, LSHTMDr Anna Last is a clinical associate professor from LSHTM, who will present on the logistical considerations and preparation required to conduct a cluster randomised trial, using the example of the MATAMAL trial.

The existing BCG vaccine has limited effect on pulmonary tuberculosis